5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one

C21H21BrN4O5 — CID 143990490

IUPAC5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one
SMILESCOc1ccc2c(c1Br)C(=O)N(C)C2.O=C1NC(=O)C(C2=CC3NC=CC=CC3O2)N1
InChIInChI=1S/C11H11N3O3.C10H10BrNO2/c15-10-9(13-11(16)14-10)8-5-6-7(17-8)3-1-2-4-12-6;1-12-5-6-3-4-7(14-2)9(11)8(6)10(12)13/h1-7,9,12H,(H2,13,14,15,16);3-4H,5H2,1-2H3
InChIKeyXWIOBGOQVBGBAT-UHFFFAOYSA-N
MW489.33 g/mol
LogP1.56
Rot. Bonds2

About 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one

5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one (PubChem CID 143990490) has the molecular formula C21H21BrN4O5 and a molecular weight of 489.33 g/mol. Its IUPAC name is 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one.

Molecular Properties

Compound Name5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one
PubChem CID143990490
Molecular FormulaC21H21BrN4O5
Molecular Weight489.33 g/mol
Exact Mass488.07
IUPAC Name5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one
SMILESCOc1ccc2c(c1Br)C(=O)N(C)C2.O=C1NC(=O)C(C2=CC3NC=CC=CC3O2)N1
InChIInChI=1S/C11H11N3O3.C10H10BrNO2/c15-10-9(13-11(16)14-10)8-5-6-7(17-8)3-1-2-4-12-6;1-12-5-6-3-4-7(14-2)9(11)8(6)10(12)13/h1-7,9,12H,(H2,13,14,15,16);3-4H,5H2,1-2H3
InChIKeyXWIOBGOQVBGBAT-UHFFFAOYSA-N
XLogP1.56
TPSA109.00 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds2
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500489.33
LogP ≤ 51.56
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one?
The IUPAC name of 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one (CID 143990490) is 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one.
What is the SMILES notation for 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one?
The canonical SMILES for 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one is COc1ccc2c(c1Br)C(=O)N(C)C2.O=C1NC(=O)C(C2=CC3NC=CC=CC3O2)N1.
What is the InChIKey of 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one?
The InChIKey is XWIOBGOQVBGBAT-UHFFFAOYSA-N. The full InChI is InChI=1S/C11H11N3O3.C10H10BrNO2/c15-10-9(13-11(16)14-10)8-5-6-7(17-8)3-1-2-4-12-6;1-12-5-6-3-4-7(14-2)9(11)8(6)10(12)13/h1-7,9,12H,(H2,13,14,15,16);3-4H,5H2,1-2H3.
What are the key properties of 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one?
5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one has a molecular weight of 489.33 g/mol, XLogP of 1.56, 2 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(4,8a-dihydro-3aH-furo[3,2-b]azepin-2-yl)imidazolidine-2,4-dione;7-bromo-6-methoxy-2-methyl-3H-isoindol-1-one is sourced from PubChem (CID 143990490), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).